A Minor Subset of Batf3-Dependent Antigen-Presenting Cells in Islets of Langerhans Is Essential for the Development of Autoimmune Diabetes

Immunity

Volumn 41, Issue 4, 2014, Pages 657-669

  Ferris, Stephen T ^a   Carrero, Javier A ^a   Mohan, James F ^a   Calderon, Boris ^a   Murphy, Kenneth M ^a   Unanue, Emil R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR BATF3; UNCLASSIFIED DRUG; ALPHA E INTEGRINS; ALPHA INTEGRIN; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CD8 ANTIGEN; CD8ALPHA ANTIGEN; EPITOPE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; HOMEODOMAIN PROTEIN; LEUKOCYTE ANTIGEN; RAG-1 PROTEIN; REPRESSOR PROTEIN; SNFT PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNE DIABETES; AUTOIMMUNE DISEASE; BONE MARROW CELL; CD103+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CONGENIC STRAIN; DENDRITIC CELL; DIABETES MELLITUS; HISTOLOGY; MACROPHAGE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET; T LYMPHOCYTE; ANIMAL; ANTIGEN PRESENTATION; AUTOIMMUNITY; BIOSYNTHESIS; CYTOLOGY; FEMALE; GENETICS; IMMUNOLOGY; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KNOCKOUT MOUSE; LANGERHANS CELL; LYMPH NODE; PANCREAS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD8; AUTOIMMUNITY; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; DIABETES MELLITUS, TYPE 1; EPITOPES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOMEODOMAIN PROTEINS; INFLAMMATION; INTEGRIN ALPHA CHAINS; ISLETS OF LANGERHANS; LANGERHANS CELLS; LYMPH NODES; MACROPHAGES; MICE; MICE, INBRED NOD; MICE, KNOCKOUT; PANCREAS; REPRESSOR PROTEINS; T-LYMPHOCYTES;

EID: 84908134654     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2014.09.012     Document Type: Article

References (56)

1. Agace W.W., Persson E.K. How vitamin A metabolizing dendritic cells are generated in the gut mucosa. Trends Immunol. 2012, 33:42-48.
2. Anderson M.S., Bluestone J.A. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 2005, 23:447-485.
3. Belz G.T., Smith C.M., Kleinert L., Reading P., Brooks A., Shortman K., Carbone F.R., Heath W.R. Distinct migrating and nonmigrating dendritic cell populations are involved in MHC class I-restricted antigen presentation after lung infection with virus. Proc. Natl. Acad. Sci. USA 2004, 101:8670-8675.
4. + dendritic cells selectively present MHC class I-restricted noncytolytic viral and intracellular bacterial antigens invivo. J.Immunol. 2005, 175:196-200.
5. + Tcells. J.Exp. Med. 1987, 166:823-832.
6. Bouma G., Coppens J.M.C., Mourits S., Nikolic T., Sozzani S., Drexhage H.A., Versnel M.A. Evidence for an enhanced adhesion of DC to fibronectin and a role of CCL19 and CCL21 in the accumulation of DC around the pre-diabetic islets in NOD mice. Eur. J. Immunol. 2005, 35:2386-2396.
7. Brezar V., Carel J.-C., Boitard C., Mallone R. Beyond the hormone: insulin as an autoimmune target in type 1 diabetes. Endocr. Rev. 2011, 32:623-669.
8. Calderon B., Unanue E.R. Antigen presentation events in autoimmune diabetes. Curr. Opin. Immunol. 2012, 24:119-128.
9. Calderon B., Suri A., Miller M.J., Unanue E.R. Dendritic cells inislets of Langerhans constitutively present beta cell-derived peptides boundto their class II MHC molecules. Proc. Natl. Acad. Sci. USA 2008, 105:6121-6126.
10. Carrero J.A., Calderon B., Towfic F., Artyomov M.N., Unanue E.R. Defining the transcriptional and cellular landscape of type 1 diabetes in the NOD mouse. PLoS ONE 2013, 8:e59701.
11. + T-cells from diabetic versus prediabetic NOD.NON-Thy-1a donors. Diabetes 1993, 42:44-55.
12. + dendritic cells. J.Exp. Med. 2010, 207:1283-1292.
13. + type. J.Immunol. 2011, 187:4411-4415.
14. Daniel D., Gill R.G., Schloot N., Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific Tcell clones isolated from NOD mice. Eur. J. Immunol. 1995, 25:1056-1062.
15. de Jersey J., Snelgrove S.L., Palmer S.E., Teteris S.A., Mullbacher A., Miller J.F.A.P., Slattery R.M. Beta cells cannot directly prime diabetogenic CD8 Tcells in nonobese diabetic mice. Proc. Natl. Acad. Sci. USA 2007, 104:1295-1300.
16. +) but not CD8(-) dendritic cells cross-prime cytotoxic Tcells invivo. J.Exp. Med. 2000, 192:1685-1696.
17. + Tcells. Immunity 2009, 31:823-833.
18. Edelson B.T., Kc W., Juang R., Kohyama M., Benoit L.A., Klekotka P.A., Moon C., Albring J.C., Ise W., Michael D.G., et al. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells. J.Exp. Med. 2010, 207:823-836.
19. Gagnerault M.-C., Luan J.J., Lotton C., Lepault F. Pancreatic lymph nodes are required for priming of beta cell reactive Tcells in NOD mice. J.Exp. Med. 2002, 196:369-377.
20. Gautier E.L., Shay T., Miller J., Greter M., Jakubzick C., Ivanov S., Helft J., Chow A., Elpek K.G., Gordonov S., et al. Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nat. Immunol. 2012, 13:1118-1128. Immunological Genome Consortium.
21. + DCs. J.Exp. Med. 2009, 206:3115-3130.
22. Grainger J.R., Askenase M.H., Guimont-Desrochers F., da Fonseca D.M., Belkaid Y. Contextual functions of antigen-presenting cells in the gastrointestinal tract. Immunol. Rev. 2014, 259:75-87.
23. + dendritic cells in cytotoxic Tcell immunity. Science 2008, 322:1097-1100.
24. Höglund P., Mintern J., Waltzinger C., Heath W., Benoist C., Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J.Exp. Med. 1999, 189:331-339.
25. Jasinski J.M., Eisenbarth G.S. Insulin as a primary autoantigen for type 1A diabetes. Clin. Dev. Immunol. 2005, 12:181-186.
26. Katz J.D., Wang B., Haskins K., Benoist C., Mathis D. Following a diabetogenic Tcell from genesis through pathogenesis. Cell 1993, 74:1089-1100.
27. Kay T.W., Parker J.L., Stephens L.A., Thomas H.E., Allison J. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J.Immunol. 1996, 157:3688-3693.
28. Krishnamurthy B., Dudek N.L., McKenzie M.D., Purcell A.W., Brooks A.G., Gellert S., Colman P.G., Harrison L.C., Lew A.M., Thomas H.E., Kay T.W. Responses against islet antigens in NOD mice are prevented by tolerance to proinsulin but not IGRP. J.Clin. Invest. 2006, 116:3258-3265.
29. Krishnamurthy B., Mariana L., Gellert S.A., Colman P.G., Harrison L.C., Lew A.M., Santamaria P., Thomas H.E., Kay T.W.H. Autoimmunity to both proinsulin and IGRP is required for diabetes in nonobese diabetic 8.3 TCR transgenic mice. J.Immunol. 2008, 180:4458-4464.
30. +) Tcells. J.Exp. Med. 1997, 186:239-245.
31. Levisetti M.G., Suri A., Frederick K., Unanue E.R. Absence of lymph nodes in NOD mice treated with lymphotoxin-beta receptor immunoglobulin protects from diabetes. Diabetes 2004, 53:3115-3119.
32. Li D.-S., Yuan Y.-H., Tu H.-J., Liang Q.-L., Dai L.-J. A protocol for islet isolation from mouse pancreas. Nat. Protoc. 2009, 4:1649-1652.
33. + Tcells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA 2003, 100:8384-8388.
34. Liu K., Nussenzweig M.C. Origin and development of dendritic cells. Immunol. Rev. 2010, 234:45-54.
35. +) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites. Immunity 2011, 35:249-259.
36. Melli K., Friedman R.S., Martin A.E., Finger E.B., Miao G., Szot G.L., Krummel M.F., Tang Q. Amplification of autoimmune responsethrough induction of dendritic cell maturation in inflamed tissues. J.Immunol. 2009, 182:2590-2600.
37. + Tcell subsets are required for the transfer of diabetes in nonobese diabetic mice. J.Immunol. 1988, 140:52-58.
38. Mohan J.F., Levisetti M.G., Calderon B., Herzog J.W., Petzold S.J., Unanue E.R. Unique autoreactive Tcells recognize insulin peptides generated within the islets of Langerhans in autoimmune diabetes. Nat. Immunol. 2010, 11:350-354.
39. + Tcells recognizing an unstable peptide of insulin are directly recruited into islets bypassing local lymph nodes. J.Exp. Med. 2013, 210:2403-2414.
40. Nakayama M., Abiru N., Moriyama H., Babaya N., Liu E., Miao D., Yu L., Wegmann D.R., Hutton J.C., Elliott J.F., Eisenbarth G.S. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 2005, 435:220-223.
41. + nonobese diabetic mice develop insulitis and diabetes. J.Exp. Med. 1993, 178:793-803.
42. + dendritic cells. J.Immunol. 2001, 166:5327-5330.
43. Satpathy A.T., Wu X., Albring J.C., Murphy K.M. Re(de)fining the dendritic cell lineage. Nat. Immunol. 2012, 13:1145-1154.
44. Serreze D.V., Leiter E.H., Christianson G.J., Greiner D., Roopenian D.C. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes 1994, 43:505-509.
45. Serreze D.V., Holl T.M., Marron M.P., Graser R.T., Johnson E.A., Choisy-Rossi C., Slattery R.M., Lieberman S.M., DiLorenzo T.P. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 Tcells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. J.Immunol. 2004, 172:871-879.
46. Stadinski B.D., Delong T., Reisdorph N., Reisdorph R., Powell R.L., Armstrong M., Piganelli J.D., Barbour G., Bradley B., Crawford F., et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat. Immunol. 2010, 11:225-231.
47. + Tcells in type 1 diabetes. Adv. Immunol. 2008, 100:79-124.
48. Unanue E.R. Antigen presentation in the autoimmune diabetes of the NOD mouse. Annu. Rev. Immunol. 2014, 32:579-608.
49. + Tcells in the initiation of insulin-dependent diabetes mellitus. Eur. J. Immunol. 1996, 26:1762-1769.
50. Wegmann D.R., Norbury-Glaser M., Daniel D. Insulin-specific Tcells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur. J. Immunol. 1994, 24:1853-1857.
51. Wicker L.S., Miller B.J., Mullen Y. Transfer of autoimmune diabetes mellitus with splenocytes from nonobese diabetic (NOD) mice. Diabetes 1986, 35:855-860.
52. Wicker L.S., Leiter E.H., Todd J.A., Renjilian R.J., Peterson E., Fischer P.A., Podolin P.L., Zijlstra M., Jaenisch R., Peterson L.B. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes 1994, 43:500-504.
53. Yamanouchi J., Verdaguer J., Han B., Amrani A., Serra P., Santamaria P. Cross-priming of diabetogenic Tcells dissociated from CTL-induced shedding of beta cell autoantigens. J.Immunol. 2003, 171:6900-6909.
54. Yin N., Xu J., Ginhoux F., Randolph G.J., Merad M., Ding Y., Bromberg J.S. Functional specialization of islet dendritic cell subsets. J.Immunol. 2012, 188:4921-4930.
55. Zhang Y., O'Brien B., Trudeau J., Tan R., Santamaria P., Dutz J.P. In situ beta cell death promotes priming of diabetogenic CD8T lymphocytes. J.Immunol. 2002, 168:1466-1472.
56. Zhang L., Nakayama M., Eisenbarth G.S. Insulin as an autoantigen in NOD/human diabetes. Curr. Opin. Immunol. 2008, 20:111-118.